Related Experiment Video
Updated: Feb 23, 2026
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
[Personalized oncology]
C Heining1, P Horak1, S Gröschel1
1Abteilung für Translationale Onkologie, Nationales Centrum für Tumorerkrankungen Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Deutschland.
Clinical Issue:
Innovative next generation sequencing (NGS) technologies and comprehensive sequencing investigations in large patient cohorts have paved the way for very promising personalized treatment strategies based on the molecular characteristics of individual tumors.
Standard Treatment:
Targeted therapies, such as tyrosine kinase inhibitors, antibodies and modern immunotherapeutic approaches are well established as monotherapy and combination therapy for many hematological and oncological malignancies.
Treatment Innovations:
A plethora of innovative therapies targeting various components of intracellular signaling cascades and effective mechanisms against oncogenes as well as the availability of NGS technologies enable personalized cancer treatment based on the molecular profiles of individual tumors and genetic stratification, within clinical trials.
Diagnostic Work-Up:
Comprehensive genetic approaches including cancer gene panel sequencing, whole exome, whole genome and transcriptome sequencing are carried out to a varying extent and particularly in the academic setting.
Performance:
Principally, a comprehensive characterization of tumors in addition to DNA and RNA sequencing that also incorporates epigenetic, metabolomic, and proteomic alterations would be desirable. A comprehensive clinical implementation of integrative, multidimensional genetic typing is, however, currently not possible.
Achievements:
It remains to be demonstrated whether these approaches will translate into significantly better outcomes for patients and whether they can be increasingly implemented in the routine diagnostic work-up.
Practical Recommendations:
The selection of diagnostic tools in individual cases and the extent of genomic analyses in the clinical context, need to take the availability of methods as well as the present clinical situation into account.
Insights
Next-generation sequencing (NGS) enables personalized cancer treatments by analyzing tumor molecular profiles. Further research is needed to confirm improved patient outcomes and routine clinical integration of these advanced genomic analyses.
Area of Science:
- Oncology
- Genomics
- Personalized Medicine
Background:
- Next-generation sequencing (NGS) technologies and large-scale patient data analysis are advancing personalized cancer treatment strategies.
- Targeted therapies, including tyrosine kinase inhibitors, antibodies, and immunotherapies, are established treatments for various hematological and oncological malignancies.
Purpose of the Study:
- To explore the role of innovative therapies and NGS in enabling personalized cancer treatment based on molecular tumor profiles and genetic stratification.
- To assess the current landscape and potential of comprehensive genetic approaches in cancer diagnostics.
Main Methods:
- Utilizing innovative therapies targeting intracellular signaling and oncogenes.
- Employing comprehensive genetic approaches such as cancer gene panel sequencing, whole exome, whole genome, and transcriptome sequencing.
- Highlighting the desirability of integrating epigenetic, metabolomic, and proteomic data alongside DNA and RNA sequencing.
Main Results:
- While comprehensive genetic characterization is desirable, full clinical implementation of integrative, multidimensional genetic typing is currently not feasible.
- The translation of these advanced sequencing approaches into significantly improved patient outcomes and routine diagnostic implementation requires further demonstration.
Conclusions:
- The selection of diagnostic tools and the scope of genomic analyses in clinical practice must consider method availability and the current clinical context.
- Further validation is necessary to establish the clinical utility and routine integration of comprehensive genomic profiling in cancer care.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:18Cancer
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
01:27Tumor Immunotherapy